Effectiveness and Tolerability of Vildagliptin plus Metformin Dual Therapy Compared with Insulin Secretagogue plus Metformin Dual Therapy in Patients with Type 2 Diabetes-A Real-World Study (China PDS)

被引：0
|
作者：
Chen, Lixian
Han, Ying
Hu, Daqing
Jin, Hui
Yang, Nailong
Shi, Xiaoyun
Li, Quanmin
Liang, Linlang
Zang, Li
Liu, Mingming
He, James
Mu, Yiming
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-2267-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Evogliptin plus Metformin Added to Insulin Therapy in Elderly Indian Patients with Type 2 Diabetes
    Guha, Shaibal
    Ranjan, Rajeev
    Gaurav, Amit
    Ranjan, Prakash
    DIABETES, 2021, 70
  • [32] Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study
    Mohan, Viswanathan
    Zargar, Abdul
    Chawla, Manoj
    Joshi, Ameya
    Ayyagari, Usha
    Sethi, Bipin
    Gaurav, Kumar
    Patted, Usha Rani H.
    Bhagat, Seema Vikas
    Mane, Amey Ishwara
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 2925 - 2933
  • [33] Long-term combination therapy with pioglitazone plus metformin for Type 2 diabetes: a randomised, comparative study with gliclazide plus metformin.
    Maher, LJ
    Edwards, GC
    Lee, CEF
    Urquhart, R
    Herz, M
    Tan, MH
    DIABETOLOGIA, 2003, 46 : A288 - A288
  • [34] Triple therapy in type 2 diabetes - Insulin glargine or rosiglitazone added to combmiation therapy of sulfonylurea plus metformin in insulin-naive patients
    Rosenstock, J
    Sugimoto, D
    Strange, P
    Stewart, JA
    Soltes-Rak, E
    Dailey, G
    DIABETES CARE, 2006, 29 (03) : 554 - 559
  • [35] Glycemic efficacy and tolerability of muraglitazar, a novel dual (α/γ) PPAR activator, plus metformin in patients with type 2 diabetes and inadequate glycemic control
    Mohideen, R
    Bancken, F
    Rubin, CJ
    DIABETOLOGIA, 2005, 48 : A274 - A275
  • [36] Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study
    Abdul-Ghani, Muhammad
    Migahid, Osama
    Megahed, Ayman
    Adams, John
    Triplitt, Curtis
    DeFronzo, Ralph A.
    Zirie, Mahmoud
    Jayyousi, Amin
    DIABETES CARE, 2017, 40 (03) : 325 - 331
  • [37] Insulin Pump Therapy in Type 1 Diabetes-a Real-World Study of Mortality and Clinical Outcomes
    Haughton, Sophie
    Riley, David
    Arshad, Muhammad Fahad
    Azmi, Shazli
    Malik, Rayaz A.
    Alam, Uazman
    Iqbal, Ahmed
    DIABETES, 2024, 73
  • [38] Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial
    Vilsboll, Tina
    Ekholm, Ella
    Johnsson, Eva
    Dronamraju, Nalina
    Jabbour, Serge
    Lind, Marcus
    DIABETES CARE, 2019, 42 (08) : 1464 - 1472
  • [39] SOLUTION study: Effect of gemigliptin as add-on therapy to dapagliflozin plus metformin in patients with type 2 diabetes
    Lee, B. W.
    Min, K. W.
    Hong, E. G.
    Ku, B. J.
    Kang, J. G.
    Chon, S.
    Kim, J. H.
    Park, M. K.
    Lee, W. Y.
    Kim, S. Y.
    Song, K. H.
    Yoo, S. J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [40] Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study
    Zang, Li
    Han, Yin
    Chen, Lixian
    Hu, Daqing
    Jin, Hui
    Yang, Nailong
    Shi, Xiaoyun
    Liang, Linlang
    Liu, Mingming
    Fan, Hong
    Li, Quanmin
    Mu, Yiming
    DIABETES THERAPY, 2019, 10 (04) : 1391 - 1405
12345